Mechanistic Insights into Phytocompounds for Vitiligo Therapy: Current Evidence and Future Opportunities
Antioxidants · 10.07.2026 · 15 (7) · 863
DOI: 10.3390/antiox15070863 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 10.07.2026. Verfasst von Rethabile Banda-Lesole und 2 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Quality of Health and Living (CQHL), Faculty of Health and Environmental Sciences, Central University of Technology, Free State, Bloemfont…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation, Stellenbosch Institute for Advanced Study (STIAS) Iso Lomso Fellowship and the Hamburg Institute of Advanced Study (HIAS) Fellowship.
Abstract (Originalsprache)
Vitiligo is a multifactorial depigmentation disorder involving complex interactions among oxidative stress, immune dysregulation, inflammatory signaling, and programmed cell death pathways, which act as a central driver of melanocyte dysfunction and loss, interacting with immune-mediated cytotoxicity and intrinsic cellular susceptibility. Excessive reactive oxygen species (ROS) disrupt mitochondrial integrity, impair redox homeostasis, suppress microphthalmia-associated transcription factor (MITF)-dependent melanogenesis, and induce melanocyte apoptosis. Concomitant dysfunction of the nuclear factor erythroid 2-related factor 2 (NRF2)/antioxidant response element (ARE) axis further exacerbates oxidative injury by limiting endogenous antioxidant capacity. Current therapeutic approaches, including corticosteroids, phototherapy, and targeted immunomodulators, achieve partial repigmentation but do not adequately resolve melanocyte-intrinsic redox imbalance. This structured narrative review comprehensively integrates mechanistic and translational evidence to define phytocompounds as redox-active, multi-target modulators in vitiligo. Plant-derived polyphenols, flavonoids, terpenoids, and related metabolites are shown to attenuate ROS accumulation, preserve mitochondrial function, activate NRF2-dependent antioxidant signaling, and restore MITF-mediated expression of tyrosinase and associated melanogenic enzymes. Furthermore, coordinated modulation of MAPK, PI3K/Akt, and JAK/STAT pathways highlights their capacity to regulate immune–oxidative crosstalk and promote melanocyte survival. Despite promising preclinical and emerging clinical evidence of repigmentation efficacy, translational progress remains limited by poor phytochemical standardization, insufficient transcriptional and proteomic validation, suboptimal stability and dermal bioavailability, and a lack of rigorously designed clinical trials. Collectively, this review provides a mechanistic framework linking redox dysregulation to melanocyte failure and positions phytocompounds as rational candidates for adjunctive or stand-alone antioxidant-based therapies, while defining critical priorities for clinical translation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Quality of Health and Living (CQHL), Faculty of Health and Environmental Sciences, Central University of Technology, Free State, Bloemfontein 9301, South Africa.
- Stellenbosch Institute for Advanced Study (STIAS), Wallenberg Research Centre, Stellenbosch University, Stellenbosch 7600, South Africa.
- Hamburg Institute for Advanced Study (HIAS), Rothenbaumchaussee 45, 20148 Hamburg, Germany.
ORCID-Profile: Tshepiso Jan Makhafola
Förderung
- National Research Foundation
- Stellenbosch Institute for Advanced Study (STIAS) Iso Lomso Fellowship and the Hamburg Institute of Advanced Study (HIAS) Fellowship
Zitieren
APA
Banda-Lesole, R., Kgosiemang, I. K. R., & Makhafola, T. J. (2026). Mechanistic Insights into Phytocompounds for Vitiligo Therapy: Current Evidence and Future Opportunities. Antioxidants, 15(7), 863. https://doi.org/10.3390/antiox15070863
Vancouver
Banda-Lesole R, Kgosiemang IKR, Makhafola TJ. Mechanistic Insights into Phytocompounds for Vitiligo Therapy: Current Evidence and Future Opportunities. Antioxidants. 2026;15(7):863. doi:10.3390/antiox15070863
BibTeX
@article{BandaLesole2026,
author = {Banda-Lesole, Rethabile and Kgosiemang, Ipeleng Kopano Rosinah and Makhafola, Tshepiso Jan},
title = {Mechanistic Insights into Phytocompounds for Vitiligo Therapy: Current Evidence and Future Opportunities},
journal = {Antioxidants},
year = {2026},
volume = {15},
number = {7},
pages = {863},
doi = {10.3390/antiox15070863}
}
EUVIMED